Mangoceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $133 | $163 | $214 | $244 |
Gross Profit | 82 | 69 | 147 | 142 |
EBITDA | -1,757 | -2,165 | -2,361 | |
EBIT | -1,758 | -2,168 | -2,367 | |
Net Income | -1,999 | -2,390 | -2,367 | -2,568 |
Net Change In Cash | 133 | 163 | 214 | 244 |
Free Cash Flow | -1,165 | -1,577 | -991 | -1,697 |
Cash | 73 | 490 | 15 | 739 |
Basic Shares | 2,013 | 26,099 | 22,832 | 1,427 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $731 | $8 |
Gross Profit | 431 | 4 |
EBITDA | -9,187 | -1,987 |
EBIT | -9,212 | -1,991 |
Net Income | -9,212 | -1,998 |
Net Change In Cash | 731 | 8 |
Free Cash Flow | -7,000 | -1,389 |
Cash | 739 | 682 |
Basic Shares | 1,427 | 17,315 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.99 |
2024-06-30 | -$1.37 |
2024-03-31 | -$1.55 |
2023-12-31 | -$1.79 |
